USFDA inspects contract manufacturing facility of Jubilant Pharmova at Montreal Canada
The US FDA in its communication mentioned it may withhold approval of any pending applications or supplements in which this facility is listed.
The US FDA in its communication mentioned it may withhold approval of any pending applications or supplements in which this facility is listed.
Capnopharm’s new CapnoPen is the first PIPAC nebulizer to obtain CE marking under the new MDR regulation 2017/745
Dr. Mandaviya urged the stakeholders to capitalize on the current opportunities
Two patents were filed during the quarter ended 31st March, 2023 and the cumulative filings till date are 3239
Product deliveries scheduled in Q3 of 2023
Unani Medicine facilities to be upgraded at Hyderabad, Chennai, Lucknow, Silchar and Bengaluru
Continues to Expand its Presence in South India
The company has reported total income of Rs. 3276.35 crores during the period ended March 31, 2023
The drug discovery of mRNA-targeted small molecules is rapidly gaining attention due to the current difficulty of developing drugs against conventional protein targets
Subscribe To Our Newsletter & Stay Updated